Precipitation of overt encephalopathy in the portacaval shunted rat towards the development of an adequate model of chronic portal systemic encephalopathy

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 3, 1997, Pages 293-298

  Mullen, Kevin D ^a   Roessle, Martin ^a   Jones, D Brian ^a   Grun, Martin ^b   Jones, E Anthony ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b St Vinzenz und Elizabeth Hospital   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Blood gavage; Cirrhosis; Encephalopathy; Meat diet; Partial hepatectomy; Portacaval shunt; Rat

Indexed keywords

AMMONIA; NITROGEN DERIVATIVE;

AMMONIA BLOOD LEVEL; ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLOOD; CHRONIC DISEASE; DIET; EXPERIMENTAL LIVER CIRRHOSIS; HEPATIC ENCEPHALOPATHY; HORSE; LIVER FUNCTION; MALE; MEAT; NONHUMAN; PARTIAL HEPATECTOMY; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RAT; SYSTEMIC DISEASE;

EID: 0030947820     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199703000-00014     Document Type: Article

References (36)

1. Conn HO: Hepatic encephalopathy. In Diseases of the Liver. Edited by Schiff L, Schiff ER. Philadelphia: Lippincott; 1993:1036-1061.
2. Bircher J: The rat with porta-caval shunt: an animal model with chronic hepatic failure. Pharmacol Ther 1979, 5:219-222.
3. Coy DL, Zee P, Blei AT: Quantitating hepatic encephalopathy in rats after portacaval anastomosis. Hepatology 1992, 16:278-279.
4. Conjeevaran HS, Mullen KD, May EJ, et al.: Gender dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt. Hepatology 1994, 19:381-388.
5. Steindl PE, Gottstein J, Blei AT: Disruption of circadian locomotor activity in rats after porta-caval anastomosis is not gender dependent. Hepatology 1995, 22:1763-1768.
6. Mullen KD, McCullough AJ: Problems with animal models of chronic liver disease. Suggestions for improvement and standardization. Hepatology 1989, 9:500-503.
7. Lee SH, Fisher B: Porta-caval shunt in the rat. Surgery 1961, 50:668-672.
8. McLean EK, McLean AM, Sutton PM: Instant cirrhosis. Br J Exp Pathol 1969, 50:502-506.
9. Higgins GM, Anderson RM: Experimental pathology of liver. Restoration of liver of white rat following surgical removal. Arch Pathol 1931, 12:186-202.
10. Blitzer BL, Waggoner JC, Jones EA, et al.: A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978, 74:664-671.
11. Traber PC, Ganger DR, Blei AT: Brain edema in rabbits with galactosamine-induced fulminant hepatic failure. Gastroenterology 1986, 91:1347-1356.
12. Traber PG, Canto MD, Blei AT: Electron microscopic evaluation of brain in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 1987, 7:1272-1277.
13. Mullen KD, Schafer DF, Cuchi P, et al.: Evaluation of the suitability of galactosamine-induced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and the rabbit. In Advances in Ammonia Metabolism and Hepatic Encephalopathy. Edited by Soeters PB, Wilson JHP, Meijer AJ, et al. Amsterdam: Elsevier; 1988:205-212.
14. Zimmermann C, Ferenci P, Pifl C, et al.: Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acidergic neurotransmission. Hepatology 1989, 9:594-601.
15. Gammal SH, Basile AS, Geller D, et al.: Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 1990, 11:371-370.
16. Basile AS, Jones EA, Skolnick P: The pathogenesis and treatment of hepatic encephalopathy: Evidence for the involvement of benzodiazepine receptor ligands. Pharmacol Rev 1991, 43:27-71.
17. Huet PM, Rochelot B, Pomier-Layrargues G, et al.: Blood-brain barrier in dogs with and without hepatic encephalopathy. In Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Edited by Kleinberger C, Ferenci P, Riederer P, et al. Basel: Karger; 1984:261-271.
18. Baraldi M, Zeneroli ML, Ventura E, et al.: Portal-systemic encephalopathy in dogs: changes in CABA receptors and neurochemical correlates. In Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Edited by Kleinberger G, Ferenci P, Riederer P, et al. Basel: Karger: 1984:353-359.
19. Thompson JS, Schafer DF, Haun J, et al.: Adequate diet prevents hepatic encephalopathy in dogs with Eck fistulas. Surg Gynecol Obstet 1986, 162:126-131.
20. Warbritton JD, Geyer MA, Jeppson B, et al.: Decreased startle reactivity in the end-to-side-porta-caval shunted rat. Pharmacol Biochem Behav 1980, 12:739-742.
21. Castaing D, Beaubernard CH, Ariogul O, et al.: Liver atrophy and encephalopathy after porta-caval shunt in the rat. Eur Surg RfS 1982, 14:192-202.
22. Grange D, Chauvand S, Thangapregassam MJ, et al.: Electroencephalographic disturbances after porta-caval shunt in the rat: a quantitative evaluation. Biomedicine 1975, 23:76-78.
23. Beaubernard CF, Salomon F, Grange D, et al.: Experimental hepatic encephalopathy: changes of the level of wakefulness in the rat with porta-caval shunt. Biomedicine 1977, 27:169-171.
24. Grun M, Liehr H: Biological consequences of porta-caval collateral circulation: significance of pancreatic venous blood. Acta Hepato-Gastroenterol 1978, 25:89-96.
25. De Boer JEG, Oestenbroek RJ, van Donjen JJ, et al.: Sequential metabolic characteristics following porta-caval shunts in rats. Eur Surg Res 1986, 18:96-106.
26. Ehrlich M, Plum F, Duffy TE. Blood and brain ammonia concentrations after porta-caval anastomosis. Effects of acute ammonia loading. J Neurochem 1980, 34:1538-1542.
27. Giguere J-F, Butterworth RF: Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 1984, 9:1309-1321.
28. Pilbeam CM, Anderson RM, Chathal PS: The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models. J Pathol 1985, 140:331-345.
29. Cruz NF, Duffy TE: Local cerebral glucose metabolism in rats with chronic porta-caval shunts. J Cereb Blood Flow Metab 1983, 3:311-320.
30. Bismuth H, Berthelot P, Desbuquois B, et al.: L'anastomose porta-caval experimentale chez le rat normal. Rev Fr Etud Clin Biol 1964, IX:608-613.
31. Lauterburg BH, Sautter V, Preisig R, et al.: Hepatic functional deterioration after porta-caval shunt in the rat. Gastroenterology 1976, 71:221-227.
32. Schroder R, Muller O, Bircher J: The porta-caval and splenorenal shunt in the normal rat. A morphometric and functional re-evaluation. J Hepatol 1985, 1:107-123.
33. Martin P, Ferreira MR, Gammal SH, et al.: The rat with carbon tetrachloride-induced cirrhosis as a model of hepatic encephalopathy. In Hepatic Encephalopathy. Pathophysiology and Treatment. Edited by Butterworth RF, Pomier Layrargues G. Clifton, NJ: Humana Press; 1989:261-270.
34. Iles JF, Jack JJB: Ammonia: assessment of its action on post-synaptic inhibition as a cause of convulsions. Brain 1983, 103:555-578.
35. Raabe W: Synaptic transmission in ammonia intoxication. Neurochem Pathol 1987, 6:145-166.
36. Jones DB, Mullen KD, Roessle M, et al.: Hepatic encephalopathy: application of visual evoked responses to test hypotheses of its pathogenesis in rats. J Hepatol 1987, 4:118-126.